ID   EPOR_RAT                Reviewed;         507 AA.
AC   Q07303;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   24-JUL-2024, entry version 158.
DE   RecName: Full=Erythropoietin receptor {ECO:0000303|PubMed:7684373};
DE            Short=EPO-R;
DE   Flags: Precursor;
GN   Name=Epor;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM EPOR-F).
RC   TISSUE=Pheochromocytoma;
RX   PubMed=7684373; DOI=10.1016/s0021-9258(18)82112-3;
RA   Masuda S., Nagao M., Takahata K., Konishi Y., Gallyas F., Tabira T.,
RA   Sasaki R.;
RT   "Functional erythropoietin receptor of the cells with neural
RT   characteristics. Comparison with receptor properties of erythroid cells.";
RL   J. Biol. Chem. 268:11208-11216(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS EPOR-F AND EPOR-S), AND TISSUE
RP   SPECIFICITY.
RC   STRAIN=Long Evans;
RX   PubMed=9029168; DOI=10.1016/s0304-3835(96)04544-2;
RA   Fujita M., Takahashi R., Kitada K., Watanabe R., Kitazawa S., Ashoori F.,
RA   Liang P., Saya H., Serikawa T., Maeda S.;
RT   "Alternative splicing of the erythropoietin receptor gene correlates with
RT   erythroid differentiation in rat hematopoietic and leukemic cells.";
RL   Cancer Lett. 112:47-55(1997).
CC   -!- FUNCTION: Receptor for erythropoietin, which mediates erythropoietin-
CC       induced erythroblast proliferation and differentiation (By similarity).
CC       Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5
CC       signaling cascade (By similarity). In some cell types, can also
CC       activate STAT1 and STAT3 (By similarity). May also activate the LYN
CC       tyrosine kinase (By similarity). {ECO:0000250|UniProtKB:P14753,
CC       ECO:0000250|UniProtKB:P19235}.
CC   -!- FUNCTION: Isoform EPOR-T acts as a dominant-negative receptor of EPOR-
CC       mediated signaling. {ECO:0000250|UniProtKB:P19235}.
CC   -!- SUBUNIT: Forms homodimers on EPO stimulation. The tyrosine-
CC       phosphorylated form interacts with several SH2 domain-containing
CC       proteins including LYN, the adapter protein SH2B2, PTPN6, PTPN11, JAK2,
CC       PI3 kinases, STAT5A/B, SOCS3, CRKL (By similarity). Interacts with
CC       INPP5D/SHIP1 (By similarity). SH2B2 binding inhibits the JAK-STAT
CC       signaling. Interacts with RHEX; this interaction occurs in a
CC       erythropoietin (EPO)-dependent manner. Interacts with ATXN2L (By
CC       similarity). {ECO:0000250|UniProtKB:P14753,
CC       ECO:0000250|UniProtKB:P19235}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P14753};
CC       Single-pass type I membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=EPOR-F; Synonyms=Full-length form;
CC         IsoId=Q07303-1; Sequence=Displayed;
CC       Name=EPOR-S; Synonyms=Soluble form;
CC         IsoId=Q07303-2; Sequence=VSP_009514, VSP_009515;
CC   -!- TISSUE SPECIFICITY: [Isoform EPOR-F]: Expressed in bone marrow, spleen
CC       and eythroleukemia cell lines. {ECO:0000269|PubMed:9029168}.
CC   -!- TISSUE SPECIFICITY: [Isoform EPOR-S]: Expressed in bone marrow, spleen
CC       and eythroleukemia cell lines. {ECO:0000269|PubMed:9029168}.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding. {ECO:0000250|UniProtKB:P19235}.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation. {ECO:0000250|UniProtKB:P16310}.
CC   -!- DOMAIN: Contains 1 copy of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC       {ECO:0000250|UniProtKB:P14753}.
CC   -!- PTM: On EPO stimulation, phosphorylated on C-terminal tyrosine residues
CC       by JAK2 (By similarity). The phosphotyrosine motifs are also
CC       recruitment sites for several SH2-containing proteins and adapter
CC       proteins which mediate cell proliferation (By similarity).
CC       Phosphorylation on Tyr-455 is required for PTPN6 interaction, Tyr-425
CC       for PTPN11 (By similarity). Tyr-425 is also required for SOCS3 binding,
CC       but Tyr-453/Tyr-455 motif is the preferred binding site (By
CC       similarity). {ECO:0000250|UniProtKB:P14753,
CC       ECO:0000250|UniProtKB:P19235}.
CC   -!- PTM: Ubiquitinated by the ECS(SOCS2) complex following ligand-binding
CC       and phosphorylation by JAK2, leading to its degradation by the
CC       proteasome (By similarity). Regulation by the ECS(SOCS2) complex acts
CC       as a negative feedback loop of erythropoietin-mediated signaling
CC       pathway (By similarity). Ubiquitination at Lys-280 mediates receptor
CC       internalization, whereas ubiquitination at Lys-452 promotes trafficking
CC       of activated receptors to the lysosomes for degradation (By
CC       similarity). Ubiquitinated by NOSIP; appears to be either multi-
CC       monoubiquitinated or polyubiquitinated (By similarity). Ubiquitination
CC       mediates proliferation and survival of EPO-dependent cells (By
CC       similarity). {ECO:0000250|UniProtKB:P14753,
CC       ECO:0000250|UniProtKB:P19235}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 1
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13566; BAA02761.1; -; mRNA.
DR   PIR; A46713; A46713.
DR   AlphaFoldDB; Q07303; -.
DR   SMR; Q07303; -.
DR   STRING; 10116.ENSRNOP00000017369; -.
DR   GlyCosmos; Q07303; 1 site, No reported glycans.
DR   GlyGen; Q07303; 1 site.
DR   iPTMnet; Q07303; -.
DR   PhosphoSitePlus; Q07303; -.
DR   PaxDb; 10116-ENSRNOP00000017369; -.
DR   Ensembl; ENSRNOT00055021579; ENSRNOP00055017493; ENSRNOG00055012644. [Q07303-1]
DR   Ensembl; ENSRNOT00060050635; ENSRNOP00060042129; ENSRNOG00060029173. [Q07303-1]
DR   UCSC; RGD:2560; rat. [Q07303-1]
DR   AGR; RGD:2560; -.
DR   RGD; 2560; Epor.
DR   eggNOG; ENOG502RYHW; Eukaryota.
DR   InParanoid; Q07303; -.
DR   PhylomeDB; Q07303; -.
DR   Reactome; R-RNO-9006335; Signaling by Erythropoietin.
DR   Reactome; R-RNO-9027276; Erythropoietin activates Phosphoinositide-3-kinase (PI3K).
DR   Reactome; R-RNO-9027284; Erythropoietin activates RAS.
DR   PRO; PR:Q07303; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0004900; F:erythropoietin receptor activity; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISO:RGD.
DR   GO; GO:1904374; P:cellular response to kainic acid; IEP:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0046697; P:decidualization; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISO:RGD.
DR   GO; GO:0030097; P:hemopoiesis; IBA:GO_Central.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:1901033; P:positive regulation of response to reactive oxygen species; IMP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   InterPro; IPR009167; Erythropoietin_rcpt.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR015152; Growth/epo_recpt_lig-bind.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003528; Long_hematopoietin_rcpt_CS.
DR   PANTHER; PTHR23037; CYTOKINE RECEPTOR; 1.
DR   PANTHER; PTHR23037:SF28; ERYTHROPOIETIN RECEPTOR; 1.
DR   Pfam; PF09067; EpoR_lig-bind; 1.
DR   Pfam; PF00041; fn3; 1.
DR   PIRSF; PIRSF001959; EPO_receptor; 1.
DR   SMART; SM00060; FN3; 1.
DR   SUPFAM; SSF49265; Fibronectin type III; 2.
DR   PROSITE; PS50853; FN3; 1.
DR   PROSITE; PS01352; HEMATOPO_REC_L_F1; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Disulfide bond; Glycoprotein;
KW   Isopeptide bond; Membrane; Phosphoprotein; Receptor; Reference proteome;
KW   Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..507
FT                   /note="Erythropoietin receptor"
FT                   /id="PRO_0000010871"
FT   TOPO_DOM        25..249
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        250..272
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        273..507
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          146..246
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          384..423
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          466..507
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           232..236
FT                   /note="WSXWS motif"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOTIF           281..289
FT                   /note="Box 1 motif"
FT                   /evidence="ECO:0000250|UniProtKB:P16310"
FT   MOTIF           451..456
FT                   /note="ITIM motif"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   COMPBIAS        396..423
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            116
FT                   /note="Required for ligand binding"
FT                   /evidence="ECO:0000250|UniProtKB:P19235"
FT   MOD_RES         367
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         425
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         453
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         455
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         467
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         484
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         488
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   MOD_RES         503
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   CARBOHYD        75
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        52..62
FT                   /evidence="ECO:0000250|UniProtKB:P19235"
FT   DISULFID        90..106
FT                   /evidence="ECO:0000250|UniProtKB:P19235"
FT   CROSSLNK        280
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   CROSSLNK        452
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:P14753"
FT   VAR_SEQ         246..265
FT                   /note="DLDPLILTLSLILVLISLLL -> GEATVPRGGGGAGPNTSKPP (in
FT                   isoform EPOR-S)"
FT                   /evidence="ECO:0000303|PubMed:9029168"
FT                   /id="VSP_009514"
FT   VAR_SEQ         266..507
FT                   /note="Missing (in isoform EPOR-S)"
FT                   /evidence="ECO:0000303|PubMed:9029168"
FT                   /id="VSP_009515"
SQ   SEQUENCE   507 AA;  55500 MW;  AC79AF22D06A7312 CRC64;
     MDQLRVARWP RVSPLCLLLA GAAWASSPSL PDPKFESKAA LLASRGSEEL LCFTQRLEDL
     VCFWEEAANS GMGFNYSFSY QLEGESRKSC RLHQAPTVRG SMRFWCSLPT ADTSSFVPLE
     LQVTEASGSP RYHRIIHINE VVLLDAPAGL LARRAEEGSH VVLRWLPPPG APMTTHIRYE
     VDVSAGNRAG GTQRVEVLEG RTECVLSNLR GGTRYTFAVR ARMAEPSFSG FWSAWSEPAS
     LLTASDLDPL ILTLSLILVL ISLLLTVLAL LSHRRALRQK IWPGIPSPEN EFEGLFTTHK
     GNFQLWLLQR DGCLWWSPSS PFPEDPPAHL EVLSERRWGV TQAGDAGAED KGPLLEPVGS
     ERAQDTYLVL DEWLLPRCPC SENLSGPGDS VDPATMDEGS ETSSCPSDLA SKPRPEGTSP
     SSFEYTILDP SSKLLCPRAL PPELPPTPPH LKYLYLVVSD SGISTDYSSG GSQGVHGDSS
     DGPYSHPYEN SLVPDTEPLR PSYVACS
//
